Author:
Wei Yan,Chang Lijia,Hashimoto Kenji
Funder
Japan Agency for Medical Research and Development
AMED
China Scholarship Council
Japan China Sasakawa Medical Fellowship
Dainippon-Sumitomo
Otsuka
Taisho
Subject
Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry
Reference142 articles.
1. Rapamycin, an Immunosuppressant and mTORC1 Inhibitor, Triples the Antidepressant Response Rate of Ketamine at 2 Weeks Following Treatment: A Double-blind, Placebo-Controlled, Cross-over, Randomized Clinical Trial. bioRxiv, 500959;Abdallah,2018
2. (R)-ketamine induces a greater increase in prefrontal 5-HT release than (S)-ketamine and ketamine metabolites via an AMPA receptor-independent mechanism;Ago;Int. J. Neuropsychopharmacol.,2019
3. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate;Anis;Br. J. Pharmacol.,1983
4. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses;Autry;Nature,2011
5. Ketamine as a rapid-acting agent for suicidal ideation: a meta-analysis;Bartoli;Neurosci. Biobehav. Rev.,2017
Cited by
123 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献